UBS Hikes Meta Platforms' Target From $872 to $908: Is the GenAI Ad Revenue Machine Just Warming Up?

"UBS points to GenAI-driven ad revenue growth as the primary engine behind the revised target, with additional upside from potential updates on AI chatbot and other monetization initiatives following Muse's release."

"In Q4 2025, Meta Platforms' ad impressions rose 18% year over year while average price per ad climbed 6%. CFO Susan Li noted that a new runtime model resulted in a 3% increase in conversion rates."

"The firm expects upward EPS and valuation revisions to continue through 2026 as these initiatives mature. They're compounding advantages that build on each other quarter after quarter."

UBS raised its price target for Meta Platforms from $872 to $908, maintaining a Buy rating. The firm emphasizes GenAI-driven ad revenue growth as a key factor, predicting upward EPS and valuation revisions through 2026. In contrast, BofA lowered its target to $820 due to near-term ad-spend concerns. UBS believes that GenAI tailwinds are accelerating, supported by strong ad data showing an 18% increase in ad impressions and a 6% rise in average ad prices in Q4 2025. Meta's user base reached 3.58 billion daily active users.

Read at 24/7 Wall St.